Saxagliptin may pose heart failure risk
Clinical Advisor
In a statement, the agency said that the probe was spurred by “a study published [last September] in the New England Journal of Medicine, which reported an increased rate of hospitalization for heart failure.” The NEJM study did not find that …
FDA looks at possible heart failure link with AZ’s OnglyzaPharmaTimes
FDA to review heart failure risk with AstraZeneca diabetes drugThe Pharma Letter
FDA Investigating Heart Failure Risk Linked To OnglyzaForbes
U.S. News & World Report –Family Practice News Digital Network
all 39 news articles »

£1-a-month drug could HALVE risk of prostate cancer: Heart failure medication …
Daily Mail
Drug company giants like GlaxoSmithKline eventually turned it into a tablet called digoxin, used for heart failure as well as atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke. It has been used for decades on the NHS and …

and more »

FDA looks at possible heart failure link with AZ’s Onglyza
PharmaTimes
The agency will review Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin/metformin) after a study published in the New England Journal of Medicine reported an increased rate of hospitalisation for heart failure with use of the drugs. The FDA …
FDA Investigating Heart Failure Risk Linked To OnglyzaForbes
FDA to probe saxagliptin’s heart failure riskFamily Practice News Digital Network
FDA Investigating Heart Failure Risks with SaxagliptinDrug Discovery & Development
HealthDay
all 34 news articles »

Medication and diet are important pieces of treating heart failure
Ravalli Republic
As we discussed in the last health column, there are two kinds of heart failure – the kind where the heart does not relax well (diastolic heart failure), and the kind where the heart does not pump well (systolic heart failure). Patients can have either …

Mini-VADs could transform heart failure therapy
Family Practice News Digital Network
SNOWMASS, COLO. – Survival in patients with advanced heart failure who receive a left ventricular assist device as destination therapy or as a bridge to transplant has increased dramatically in recent years – and the best may be yet to come. “There is …

FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure Risk
U.S. News & World Report
TUESDAY, Feb. 11, 2014 (HealthDay News) — The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users. In a statement, the …
FDA Investigating Heart Failure Risk Linked To OnglyzaForbes
FDA to review heart failure risk associated with saxagliptinHealio
FDA to review heart failure risk with AstraZeneca diabetes drugThe Pharma Letter
Clinical Endocrinology News Digital Network –Science World Report –MedPage Today
all 39 news articles »

FDA Investigating Heart Failure Risks with Saxagliptin
Drug Discovery & Development
The U.S. Food and Drug Administration (FDA) has requested clinical trial data from the manufacturer of saxagliptin, which is co-developed by AstraZeneca and Bristol-Myers Squibb Co., to investigate a possible association between use of the type 2 …

Heart Failure Awareness
WALA-TV FOX10
Did you know it’s Heart Failure Awareness Week? Heart failure is a condition that affects nearly five million Americans of all ages and is responsible for more hospitalizations than all forms of cancer combined. Dr. Partick Murphy, a Cardiologist at …

and more »

FDA Investigating Heart Failure Risk Linked To Onglyza
Forbes
ureThe FDA said today that it was conducting an investigation of a possible increased risk for heart failure associated with the diabetes drug saxagliptin. Saxagliptin is marketed by AstraZeneca AstraZeneca as Onglyza and Kombiglyze XR. (AstraZeneca …
FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure RiskU.S. News & World Report
FDA to probe saxagliptin’s heart failure riskFamily Practice News Digital Network
FDA Investigating Heart Failure Risks with SaxagliptinDrug Discovery & Development
Healio
all 27 news articles »